HomeGeneticsConditionRecurrent hydatidiform mole
Back to Condition
Recurrent hydatidiform mole
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Recurrent hydatidiform mole

Recurrent hydatidiform mole is a condition characterized by the occurrence of at least two abnormal pregnancies resulting in the formation of a mass of cells from an abnormally developed embryo and placenta.

Overview

A hydatidiform mole is a mass that forms early in pregnancy. While a sporadic mole occurs once, the recurrent form involves multiple occurrences. The first symptom is often vaginal bleeding in the first trimester. These moles must be surgically removed, as they do not discharge naturally. There is a risk that remaining tissue can become a persistent mole or an invasive mole, and in rare cases, it can transform into a cancer called gestational choriocarcinoma.

Causes

Mutations in the NLRP7 and KHDC3L genes are the primary causes of this condition. These genes are critical for normal egg cell (oocyte) development and are thought to play a role in genomic imprinting—a process where certain genes are turned off based on which parent they were inherited from. Mutations lead to impaired protein function, resulting in abnormal oocytes that cannot develop into a healthy pregnancy.

Rarely, mutations in genes involved in the production of oocytes and sperm cells—specifically those involved in the exchange of genetic material during cell division—can also cause the condition. These mutations result in oocytes that lack chromosomes, leading to an embryo that cannot develop normally.

Genes Associated with Recurrent hydatidiform mole

  • KHDC3L
  • NLRP7

Inheritance

Recurrent hydatidiform mole is inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell must have mutations for the condition to occur. Parents of an affected individual typically carry one copy of the mutated gene but do not show symptoms themselves.

Frequently Asked Questions

Treatment usually involves a hysteroscopic curettage to remove remaining tissue, followed by close monitoring of hCG levels every 1–2 weeks until they return to normal. In some cases, low‑dose chemotherapy may be needed. Recovery to normal hCG levels typically takes 4–6 weeks, but follow‑up visits continue for several months to ensure complete resolution.
Persistent vaginal bleeding lasting more than a week, high fever, severe abdominal pain, or signs of infection (e.g., chills, foul discharge) should prompt immediate medical attention, as they may indicate a persistent or invasive mole.
Meet with a reproductive geneticist to review your family history, discuss the autosomal recessive inheritance pattern, and consider testing for NLRP7 or KHDC3L mutations in both partners. This information helps estimate recurrence risk and plan appropriate monitoring.
Consider early prenatal care with serial ultrasounds and beta‑hCG monitoring, and discuss assisted reproductive technologies that allow for pre‑implantation genetic testing to screen for chromosomal abnormalities. Lifestyle factors such as maintaining a healthy weight and avoiding smoking also support overall reproductive health.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA